“Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure” (2025) Voprosy onkologii, 71(5), p. OF-2520. doi:10.37469/0507-3758-2025-71-5-OF-2520.